Dr. Elie G. Dib
Claim this profileSaint Joseph Mercy Hospital
Expert in Cancer
Studies Breast Cancer
34 reported clinical trials
94 drugs studied
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
EGFR negative
2Breast Cancer
HER2 negative
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Elie G. Dib is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
BRAF-Targeted Therapy
for Colon Cancer
This phase II/III trial compares treatment with encorafenib and cetuximab to usual care (patient observation) for reducing the chance of cancer recurrence after standard surgery and chemotherapy in patients with BRAF-mutated stage IIB-III colon cancer. Encorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cetuximab is in a class of medications called monoclonal antibodies. It binds to a protein called EGFR, which is found on some types of tumor cells. This may help keep tumor cells from growing. Giving encorafenib and cetuximab after standard surgery and chemotherapy may be more effective at reducing the chance of cancer recurrence compared to the usual patient observation.
Recruiting1 award Phase 2 & 3
More about Elie G. Dib
Clinical Trial Related4 years of experience running clinical trials · Led 34 trials as a Principal Investigator · 20 Active Clinical TrialsTreatments Elie G. Dib has experience with
- Nivolumab
- Lenalidomide
- Atezolizumab
- Dexamethasone
- Durvalumab
- Pembrolizumab
Breakdown of trials Elie G. Dib has run
Cancer
Breast Cancer
Multiple Myeloma
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elie G. Dib specialize in?
Elie G. Dib focuses on Cancer and Breast Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Elie G. Dib currently recruiting for clinical trials?
Yes, Elie G. Dib is currently recruiting for 19 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Elie G. Dib has studied deeply?
Yes, Elie G. Dib has studied treatments such as Nivolumab, Lenalidomide, Atezolizumab.
What is the best way to schedule an appointment with Elie G. Dib?
Apply for one of the trials that Elie G. Dib is conducting.
What is the office address of Elie G. Dib?
The office of Elie G. Dib is located at: Saint Joseph Mercy Hospital, Ann Arbor, Michigan 48106 United States. This is the address for their practice at the Saint Joseph Mercy Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.